RVL Pharmaceuticals plc (RVLP) Company Profile & Statistics

RVL Pharmaceuticals plc
RVLP
(Nasdaq - US)
Closed
1.41
+0.02 (+1.44%)
in:usd•As of: Jan 27, 2023 15:59 UTC -5
Open
1.37
High
1.41
Low
1.37

About RVL Pharmaceuticals plc

CEO

Brian Markison

Headquarters

400 crossing boulevard

bridgewater, nj 08807, united states

Auditor

Ernst & Young LLP

Employees

156

Share Holders

Website

www.rvlpharma.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

RVL Pharmaceuticals plc is a specialty pharmaceutical company. It focused on the commercialization and development of products which target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. RVL Pharmaceuticals plc, formerly known as Osmotica Pharmaceuticals plc, is based in BRIDGEWATER, N.J.

RVL Pharmaceuticals plc Statistics

Valuation Measures

Market Capitalization ²	139.80M
Enterprise Value	135.98M
Enterprise Value/EBITDA (ttm)	-2.45
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.81
Price to Sales (ttm)	2.90
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	75.14%
Operating Margin (ttm)	-147.38%
Profit Margin (ttm)	-252.21%
Return on Equity (ttm)	-92.27%
Return on Invested Capital (ttm)	-45.82%
Return on Assets (ttm)	-44.30%

Income Statement

Revenue (ttm)	42.77M
Revenue Per Share (ttm)	0.43
Gross Profit (ttm)	34.80M
EBITDA (ttm)³	-55.51M
Net Income Avi to Common (ttm)	-53.09M
Diluted EPS (ttm)	-0.62

Share Statistics

Beta (5Y Monthly)	1.17
52-Week Change	30.56%
S&P500 52-Week Change	-8.15%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	99.15M
Dividend Yield	0.00%
Float ⁴	94.01M
% Held by Insiders	5.19%
% Held by Institutions	62.91%

Balance Sheet

Total Cash (mrq)	59.75M
Total Cash Per Share (mrq)	0.60
Total Debt (mrq)	55.93M
Total Debt/Equity (mrq)	81.59%
Current Ratio (mrq)	3.30%
Quick Ratio (mrq)	3.27%
Book Value Per Share (mrq)	0.69

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.23
Free Cash Flow (ytd)	-21.08M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

RVL Pharmaceuticals plc

Trade With A Regulated Broker